Portland Life Sciences Alternative Fund Series F (PTL030)
16.62
+0.22
(+1.35%)
CAD |
Dec 11 2025
PTL030 Asset Allocations & Exposures
Asset Allocation
As of October 31, 2025.
| Type | % Net |
|---|---|
| Cash | 2.40% |
| Stock | 97.60% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Market Capitalization
| Large | -- |
| Mid | -- |
| Small | -- |
Region Exposure
| Americas | 47.78% |
|---|---|
|
North America
|
47.78% |
| Canada | 2.54% |
| United States | 45.24% |
|
Latin America
|
0.00% |
As of October 31, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 15.27% |
|---|---|
| United Kingdom | 1.04% |
|
Europe Developed
|
14.23% |
| Germany | 1.78% |
| Ireland | 4.44% |
| Switzerland | 8.01% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 37.12% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
37.12% |
| Australia | 37.12% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | -0.17% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
100.0% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
100.0% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.00% |
| Non Classified Equity |
|
0.00% |
| Not Classified - Non Equity |
|
0.00% |
As of October 31, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |